SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Transcription factor SRY-related HMG-box 10 (SOX10) is an important marker for melanocytic, schwannian, myoepithelial, and some salivary gland tumors. The aim of this study was to investigate SOX10 expression more thoroughly in the salivary gland neoplasms, including mammary analogue secretory carcinoma and hyalinizing clear cell carcinoma harboring specific genetic rearrangements. A new rabbit monoclonal anti-SOX10 antibody (clone EP268) was used to examine SOX10 expression in 14 different types of salivary gland tumors. We found that acinic cell carcinoma (AciCC), adenoid cystic carcinoma, mammary analogue secretory carcinoma (MASC), epithelial-myoepithelial carcinoma, low-grade salivary duct carcinoma, sialoblastoma, basal cell adenocarcinoma, basal cell adenoma, and pleomorphic adenoma were SOX10 positive. Salivary duct carcinoma, lymphoepithelial carcinoma, hyalinizing clear cell carcinoma, and oncocytoma were SOX10 negative. Earlier, mucoepidermoid carcinoma (MEC) was considered a SOX10-negative tumor. This study identified a subgroup of SOX10-positive MEC cases with characteristic polygonal epithelial cells, pale-to-eosinophilic cytoplasm, and colloid-like dense eosinophilic material. Our data show SOX10 expression can be observed in salivary gland tumors with either one of the 4 cell types: acinic cells, cuboidal ductal cells with low-grade cytologic features, basaloid cells, and myoepithelial cells. In this article we thoroughly evaluated SOX10 expression in salivary gland tumors. SOX10 is useful in the differential diagnosis between myoepithelial carcinoma with clear cell features and hyalinizing clear cell carcinoma. It can also be used to discriminate low-grade salivary duct carcinoma from high-grade ones. Pathologists should be cautious with the interpretation of SOX10 positivity in salivary gland tumors, and correlation with histologic feature is mandatory.
Department of Pathology, National Taiwan University Hospital and National Taiwan, University College of Medicine, Taipei, Taiwan 100; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan 100.
Min-Shu
MS
Hsieh
Department of Pathology, National Taiwan University Hospital and National Taiwan, University College of Medicine, Taipei, Taiwan 100.
Yi-Hsuan
YH
Lee
Department of Pathology, National Taiwan University Hospital and National Taiwan, University College of Medicine, Taipei, Taiwan 100; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan 100. Electronic address: ntuhylc@gmail.com.
Yih-Leong
YL
Chang
D000230:Adenocarcinoma / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D000236:Adenoma / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D001706:Biopsy; D018277:Carcinoma, Mucoepidermoid / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D003937:Diagnosis, Differential; D004847:Epithelial Cells / Q000737:chemistry* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D000069295:Mammary Analogue Secretory Carcinoma / Q000737:chemistry* / Q000235:genetics / Q000473:pathology; D060787:Neoplasm Grading; D011237:Predictive Value of Tests; D055757:SOXE Transcription Factors / Q000032:analysis*; D012468:Salivary Gland Neoplasms / Q000737:chemistry* / Q000235:genetics / Q000473:pathology
D014408:Biomarkers, Tumor; C527923:SOX10 protein, human; D055757:SOXE Transcription Factors
Mammary analogue secretory carcinoma; Mucoepidermoid carcinoma; SOX10; Salivary gland tumor; Sialoblastoma